MedPath

Peter Korsten

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

Not Applicable
Conditions
Raynaud Phenomenon
Digital Ulcer
Scleroderma
Systemic Sclerosis
Interventions
Procedure: Rheopheresis treatment
Drug: Intravenous Infusion
First Posted Date
2022-01-24
Last Posted Date
2022-03-23
Lead Sponsor
Peter Korsten
Target Recruit Count
30
Registration Number
NCT05204784
Locations
🇩🇪

University Medical Center Göttingen, Göttingen, Lower Saxony, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.